Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CONSOL Energy | CEIX | Jan 31, 2025 | 99.61 | 0.00 |
Consolidated Water | CWCO | Jan 31, 2025 | 26.18 | -0.42 |
Constellation Brands | STZ | Jan 31, 2025 | 180.80 | -1.91 |
Constellation Energy | CEG | Jan 31, 2025 | 299.98 | -2.78 |
Constellium | CSTM | Jan 31, 2025 | 9.93 | +0.40 |
Construction Partners | ROAD | Jan 31, 2025 | 80.40 | +0.47 |
Consumer Disc Alphadex First Trust | FXD | Jan 31, 2025 | 66.82 | -1.91 |
Consumer Discret Select Sector SPDR | XLY | Jan 31, 2025 | 232.17 | -0.44 |
Consumer Discretionary ETF Vanguard | VCR | Jan 31, 2025 | 390.49 | -0.32 |
Consumer Portfolio Services | CPSS | Jan 31, 2025 | 11.86 | -4.66 |
Consumer Staples Alphadex First Trust | FXG | Jan 31, 2025 | 64.85 | -0.73 |
Consumer Staples ETF Vanguard | VDC | Jan 31, 2025 | 215.33 | -0.73 |
Consumer Staples Select Sector SPDR | XLP | Jan 31, 2025 | 78.98 | -0.94 |
Consumers Energy Pref | CMS-B | Jan 31, 2025 | 77.98 | +1.12 |
Contango ORE | CTGO | Jan 31, 2025 | 10.37 | -2.08 |
Context Therapeutics | CNTX | Jan 31, 2025 | 0.91 | -4.50 |
Contextlogic A | LOGC | Jan 31, 2025 | 7.77 | +4.72 |
Contineum Therapeutics | CTNM | Jan 31, 2025 | 9.79 | -4.21 |
Continuous Commodity Index | GCC | Jan 31, 2025 | 19.55 | -0.56 |
Controladora Vuela Compania de Aviacion ADR | VLRS | Jan 31, 2025 | 8.49 | -3.08 |
Cool Company | CLCO | Jan 31, 2025 | 8.68 | -0.34 |
Cooper-Standard | CPS | Jan 31, 2025 | 15.42 | -2.28 |
Copa | CPA | Jan 31, 2025 | 93.22 | -1.50 |
Copart | CPRT | Jan 31, 2025 | 57.93 | -1.08 |
Corbus Pharmaceuticals | CRBP | Jan 31, 2025 | 9.79 | -1.11 |
Corcept Therapeutics | CORT | Jan 31, 2025 | 66.92 | -4.26 |
Core & Main A | CNM | Jan 31, 2025 | 56.44 | -1.03 |
Core Laboratories | CLB | Jan 31, 2025 | 16.97 | -4.39 |
Core Molding Technologies | CMT | Jan 31, 2025 | 14.77 | -0.61 |
Core Natural Resources | CNR | Jan 31, 2025 | 90.34 | -2.19 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.